Project Grant R34MH138250
Award Date
9/10/24
Completion Date
9/9/27
Dollars Obligated
$583K
Funding Federal Agency
National Institute of Allergy and Infectious Diseases
Awarding Federal Agency
National Institute of Mental Health
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to implement an innovative HIV self-testing and long-acting injectable HIV treatment and prevention intervention for commercial minibus drivers in Nigeria. The $809,692 award to The George Washington University, with sub-awards to Wake Forest University Health Sciences, University of Rochester, Emory...
The federal Project Grant award of $1,272,602.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support the "Integrating U=U into HIV Counseling: A Cluster-Randomized Efficacy Trial (INTUIT 2.0)" research project. The study aims to (1) refine an educational "Undetectable & You" mobile app intervention designed to disseminate information on the prevention benefits of antiretroviral therapy (ART) and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,155,836 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Miami. The funding will support a 5-year, randomized hybrid implementation/effectiveness trial titled "TEST-TO-PREP: A Randomized Hybrid Implementation/Efficacy Trial of a Social Network Strategy to Increase Equitable Reach of HIV Testing and PrEP Information." The study aims to evaluate the...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $1,415,374 to the University of Washington to evaluate the integration of HIV prevention, including HIV self-testing and pre-exposure prophylaxis (PrEP), into household-based tuberculosis (TB) contact investigation in Uganda. The overarching goals are to assess the implementation, effectiveness, and cost-effectiveness of this integrated approach to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $702,000 to support a 3-year project aimed at optimizing the implementation of long-acting injectable pre-exposure prophylaxis (LAI-PrEP) for HIV prevention. The key objectives are to: 1) Identify barriers and facilitators to LAI-PrEP implementation, 2) Determine optimal implementation strategies in partnership with...
This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...
This Project Grant award of $192,672 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is supporting Dr. Christopher Bennett of Stanford University in pursuing two key objectives: 1) investigating the cost-effectiveness of HIV screening in emergency departments (EDs) in Ending the HIV Epidemic (EHE) targeted areas compared to current screening rates, and determining the incremental...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $911,400 Project Grant to Emory University to establish the PREMISE (PrEP Epidemiology, Modeling, and Surveillance) system. The goal is to use national PrEP prescription data, legal/policy coding, and natural experimental designs to inform the U.S. HIV epidemic response and understand which programs and policies are effective at facilitating...